![](/img/cover-not-exists.png)
1512PClinicopathologic features and long-term follow-up of metastatic gastrointestinal stromal tumor (GIST) patients (pts) with durable response (≥ 5 years) to frontline imatinib (IM): A case-control study from GEIS
Serrano, C., Lopez Pousa, A., Pajares, I., Valverde Morales, C., Duran, J., Rubió-Casadevall, J., Safont, M.J., Martinez, V., Díaz Beveridge, R., Estival, A., Vicente Baz, D., Sebio Garcia, A., Hindi,Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx387.037
Date:
September, 2017
File:
PDF, 48 KB
english, 2017